SutterstockThe Real Reason Cybin Bought Entheon’s DMT Clinical TrialBusiness, Research, Stock Reports In a rare move Cybin aquires a phase 1 DMT clinical trial from Entheon Biomedical. CEO Doug Drysdale explains why in a Reddit AMA https://psychedelicspotlight.com/wp-content/uploads/2022/07/cybin-entheon-dmt.png 802 1200 James Hallifax https://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.png James Hallifax2022-07-29 19:51:012022-07-29 19:56:39The Real Reason Cybin Bought Entheon’s DMT Clinical Trial